124 related articles for article (PubMed ID: 35502774)
1. Population pharmacokinetics and dosage optimisation of tacrolimus coadministration with Wuzhi capsule in adult liver transplant patients.
Du Y; Song W; Xiong X; Ge W; Zhu H
Xenobiotica; 2022 Mar; 52(3):274-283. PubMed ID: 35502774
[TBL] [Abstract][Full Text] [Related]
2. Effect of drug combination on tacrolimus target dose in renal transplant patients with different
Zhang SF; Tang BH; Wei AH; Du Y; Guan ZW; Li Y
Xenobiotica; 2022 Mar; 52(3):312-321. PubMed ID: 35395919
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetic analysis and dosing guidelines for tacrolimus co-administration with Wuzhi capsule in Chinese renal transplant recipients.
Jing Y; Kong Y; Hou X; Liu H; Fu Q; Jiao Z; Peng H; Wei X
J Clin Pharm Ther; 2021 Aug; 46(4):1117-1128. PubMed ID: 33768546
[TBL] [Abstract][Full Text] [Related]
4. Wuzhi capsule and haemoglobin influence tacrolimus elimination in paediatric kidney transplantation patients in a population pharmacokinetics analysis: A retrospective study.
Wang DD; Chen X; Li ZP
J Clin Pharm Ther; 2019 Aug; 44(4):611-617. PubMed ID: 30864229
[TBL] [Abstract][Full Text] [Related]
5. Optimization of initial dosing scheme of tacrolimus in pediatric refractory nephrotic syndrome patients based on CYP3A5 genotype and coadministration with wuzhi-capsule.
Chen X; Wang DD; Xu H; Li ZP
Xenobiotica; 2020 May; 50(5):606-613. PubMed ID: 31530218
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetic analysis of tacrolimus in Chinese cardiac transplant recipients.
Gong Y; Yang M; Sun Y; Li J; Lu Y; Li X
Eur J Hosp Pharm; 2020 Mar; 27(e1):e12-e18. PubMed ID: 32296499
[TBL] [Abstract][Full Text] [Related]
7. Initial dose optimization of tacrolimus for children with systemic lupus erythematosus based on the CYP3A5 polymorphism and coadministration with Wuzhi capsule.
Chen X; Wang D; Xu H; Li Z
J Clin Pharm Ther; 2020 Apr; 45(2):309-317. PubMed ID: 31755126
[TBL] [Abstract][Full Text] [Related]
8. Effects of Wuzhi Capsules on Blood Concentration of Tacrolimus in Renal Transplant Recipients.
Yan L; Yang ZQ; Shi YY; Ren J; Yang CL; Wan ZL; Bai YJ; Luo LM; Wang LL; Li Y
Ann Transplant; 2019 Nov; 24():594-604. PubMed ID: 31712547
[TBL] [Abstract][Full Text] [Related]
9. Wuzhi Capsule Dosage Affects Tacrolimus Elimination in Adult Kidney Transplant Recipients, as Determined by a Population Pharmacokinetics Analysis.
Chen L; Yang Y; Wang X; Wang C; Lin W; Jiao Z; Wang Z
Pharmgenomics Pers Med; 2021; 14():1093-1106. PubMed ID: 34511980
[TBL] [Abstract][Full Text] [Related]
10. Population Pharmacokinetic Modeling Combined With Machine Learning Approach Improved Tacrolimus Trough Concentration Prediction in Chinese Adult Liver Transplant Recipients.
Li ZR; Li RD; Niu WJ; Zheng XY; Wang ZX; Zhong MK; Qiu XY
J Clin Pharmacol; 2023 Mar; 63(3):314-325. PubMed ID: 36097320
[TBL] [Abstract][Full Text] [Related]
11. Prediction of tacrolimus dosage in the early period after heart transplantation: a population pharmacokinetic approach.
Han Y; Zhou H; Cai J; Huang J; Zhang J; Shi SJ; Liu YN; Zhang Y
Pharmacogenomics; 2019 Jan; 20(1):21-35. PubMed ID: 30730287
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics of tacrolimus in Chinese adult liver transplant patients.
Teng F; Zhang W; Wang W; Chen J; Liu S; Li M; Li L; Guo W; Wei H
Biopharm Drug Dispos; 2022 Apr; 43(2):76-85. PubMed ID: 35220592
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of Wuzhi Capsule on tacrolimus blood concentrations in liver transplant patients with different donor-recipient CYP3A5 genotypes.
Kou K; Sun X; Li M; Li T; Hu Y; Li S; Lv G
J Clin Pharm Ther; 2022 Feb; 47(2):200-210. PubMed ID: 34708436
[TBL] [Abstract][Full Text] [Related]
14. Dosing recommendations based on population pharmacokinetics of tacrolimus in Mexican adult patients with kidney transplant.
Reséndiz-Galván JE; Medellín-Garibay SE; Milán-Segovia RDC; Niño-Moreno PDC; Isordia-Segovia J; Romano-Moreno S
Basic Clin Pharmacol Toxicol; 2019 Mar; 124(3):303-311. PubMed ID: 30260084
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetic analyses of tacrolimus in non-transplant patients: a systematic review.
Wang CB; Zhang YJ; Zhao MM; Zhao LM
Eur J Clin Pharmacol; 2023 Jul; 79(7):897-913. PubMed ID: 37261481
[TBL] [Abstract][Full Text] [Related]
16. Effect of hepar-protecting Wuzhi capsule on pharmacokinetics and dose-effect character of tacrolimus in healthy volunteers.
Teng F; Wang W; Zhang W; Qu J; Liu B; Chen J; Liu S; Li M; Chen W; Wei H
Biopharm Drug Dispos; 2022 Aug; 43(4):119-129. PubMed ID: 35180322
[TBL] [Abstract][Full Text] [Related]
17. Effects of traditional chinese medicine Wuzhi capsule on pharmacokinetics of tacrolimus in rats.
Wei H; Tao X; Di P; Yang Y; Li J; Qian X; Feng J; Chen W
Drug Metab Dispos; 2013 Jul; 41(7):1398-403. PubMed ID: 23628674
[TBL] [Abstract][Full Text] [Related]
18. Effects and safety evaluation of Wuzhi Capsules combined with tacrolimus for the treatment of kidney transplantation recipients.
Cheng F; Li Q; Wang J; Zeng F; Zhang Y
J Clin Pharm Ther; 2021 Dec; 46(6):1636-1649. PubMed ID: 34342024
[TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetics of tacrolimus in Thai kidney transplant patients: comparison with similar data from other populations.
Vadcharavivad S; Praisuwan S; Techawathanawanna N; Treyaprasert W; Avihingsanon Y
J Clin Pharm Ther; 2016 Jun; 41(3):310-28. PubMed ID: 27191538
[TBL] [Abstract][Full Text] [Related]
20. Factors affecting the apparent clearance of tacrolimus in Korean adult liver transplant recipients.
Lee JY; Hahn HJ; Son IJ; Suh KS; Yi NJ; Oh JM; Shin WG
Pharmacotherapy; 2006 Aug; 26(8):1069-77. PubMed ID: 16863483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]